Voltarelli J C, Gjerset G, Anasetti C
Fred Hutchinson Cancer Research Center, Seattle, Washington.
Immunology. 1993 Jul;79(3):509-11.
In order to investigate the function of CD2 and CD18 receptors in antibody-dependent cellular cytotoxicity (ADCC), Fab' fragments of the monoclonal antibodies 9.6 (anti-CD2) and 60.3 (anti-CD18) were preincubated with the human natural killer (NK) clone EB4.19 and tested for conjugate formation and cytotoxic function against the human B-cell line KMS and the mouse thymoma line SL-2. We concluded that: (1) the FcR CD16 does not participate in conjugate formation; (2) adhesion between target and effector cells mediated by CD2 and CD18 is a prerequisite for subsequent activation of the lytic programme through the CD16 receptor.
为了研究CD2和CD18受体在抗体依赖性细胞毒性(ADCC)中的作用,将单克隆抗体9.6(抗CD2)和60.3(抗CD18)的Fab'片段与人自然杀伤(NK)克隆EB4.19预孵育,并检测其与人类B细胞系KMS和小鼠胸腺瘤系SL-2的结合形成及细胞毒性功能。我们得出以下结论:(1)FcR CD16不参与结合形成;(2)由CD2和CD18介导的靶细胞与效应细胞之间的黏附是随后通过CD16受体激活裂解程序的前提条件。